Plain-English translation of NCT07153549 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a dietary supplement called Biolizin—an oral zinc product—to see if it can help young children between 6 and 36 months of age who have poor appetite or difficulty eating. The study gives some children the supplement plus counseling about responsive feeding practices, while others receive counseling alone. Researchers will measure changes in feeding difficulty and eating behavior over six weeks to understand whether the medication helps improve appetite and mealtime success.
Poor appetite in toddlers can lead to inadequate nutrition and growth problems, and it often involves both nutritional gaps and behavioral factors. Zinc plays an important role in taste perception and appetite regulation, so this trial is exploring whether boosting zinc levels through the medication—combined with parent coaching—can safely and effectively improve feeding challenges in young children.
You likely qualify if…
You likely don't qualify if…
Your child will be randomly assigned to receive either the zinc supplement syrup plus parent counseling, or counseling alone, for 42 days. You'll visit the clinic four times (at days 0, 7, 21, and 42) for check-ups, measurements, and parent education on responsive feeding. You'll keep a dosing diary if your child is assigned to take the supplement, and the research team will collect blood tests at the beginning and end to check safety. Throughout the study, the team will ask you to complete brief questionnaires about your child's feeding behavior and appetite.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Vietnam